Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL ZKAB001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ZKAB001 .LAMBDA.-CHAIN, DIMER

Extensive Stage Small Cell Lung Cancer

Lee's Pharmaceutical Limitedmonoclonal_antibodyPhase 3Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Extensive Stage Small Cell Lung Cancer cohort.

Asset / SponsorPhaseRating
Hycamtin
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 3BB
FILGRASTIM
Zhou Chengzhi
Phase 2BB
(R)-GOSSYPOL ACETIC ACID
National Cancer Institute (NCI)
Phase 2BB
7-hydroxystaurosporine
National Cancer Institute (NCI)
Phase 2BB
Irinotecan
National Cancer Institute (NCI)
Phase 2BB

View all 31 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL ZKAB001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ZKAB001 .LAMBDA.-CHAIN, DIMER is also rated in:

small cell lung carcinomaDormant
B
Indicative ·
60 / 100
View asset →
metastatic melanomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →